首页> 外国专利> Being screening manner of the curative medicine of the screening mannered null non

Being screening manner of the curative medicine of the screening mannered null non

机译:筛查的治愈药物的筛查方式为无效非

摘要

PROBLEM TO BE SOLVED: To provide a method of screening candidate medicine for curing non-alcoholic fatty liver according to abnormality/variation of a bile secretion mechanism in which MRP 2 is engaged, in the non-alcoholic fatty liver.;SOLUTION: The screening method of the curative medicine of non-alcoholic fatty liver is provided. In the screening method, a specimen is administered to the non-alcoholic fatty liver of a non-human animal, and the degree of improvement caused by the specimen is evaluated about bile drainage capability in the fatty liver. For example, the bile drainage amount, bile acid concentration in drainage bile, phospholipid concentration, and/or a ratio of bile acid concentration/phospholipid concentration is preferably measured.;COPYRIGHT: (C)2007,JPO&INPIT
机译:解决的问题:提供一种方法,其根据参与非酒精性脂肪肝的MRP 2参与的胆汁分泌机制的异常/变异,筛选用于治疗非酒精性脂肪肝的候选药物。提供了非酒精性脂肪肝的治疗方法。在该筛选方法中,将标本施用于非人类动物的非酒精性脂肪肝,并且评估由该标本引起的改善程度,以评估脂肪肝中的胆汁排出能力。例如,优选测量胆汁排出量,排出胆汁中的胆汁酸浓度,磷脂浓度和/或胆汁酸浓度/磷脂浓度的比率。COPYRIGHT:(C)2007,JPO&INPIT

著录项

  • 公开/公告号JP4918674B2

    专利类型

  • 公开/公告日2012-04-18

    原文格式PDF

  • 申请/专利权人 国立大学法人 東京医科歯科大学;

    申请/专利号JP20050175039

  • 发明设计人 工藤 篤;有井 滋樹;

    申请日2005-06-15

  • 分类号G01N33/15;G01N33/50;G01N33/92;G01N33/68;

  • 国家 JP

  • 入库时间 2022-08-21 17:37:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号